Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GPCR — Structure Therapeutics Inc. SEC Filings | FilingIndex

GPCRNasdaq

Structure Therapeutics Inc.

Pharmaceutical Preparations · E9 · CIK 1888886

Developing novel oral small molecule therapeutics for chronic diseases by targeting G-protein coupled receptors

red 8-K · 90d

+ Watch View on EDGAR ↗

$3.05B

Market cap

$51.69

Last close

+4.0%

1D

+13.6%

5D

779K

Volume

Price · last 39 sessions+20.1%

May 4L $35.88 · H $51.69Jun 29

70

Total filings

Jun 18, 2026

Last filing

12/31

Fiscal year end

All 8-K · 34 10-Q · 10 SC 13G · 8 10-K · 4 DEF 14A · 3 424B5 · 3 S-1 · 3 424B4 · 2

8-KShareholder VoteJun 18, 2026 8-KMaterial Agreement · Results of OperationsMay 7, 2026 8-KExecutive Change · Reg FD DisclosureApr 15, 2026 8-KReg FD Disclosure · Company UpdateMar 16, 2026 8-KResults of OperationsFeb 26, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

CRNXCrinetics Pharmaceuticals, Inc.$3.6B+0.7%VTVTvTv Therapeutics Inc.$129.0M+3.4%SIONSionna Therapeutics, Inc.$1.6B+1.9%KYMRKymera Therapeutics, Inc.$7.1B+1.1%GANXGain Therapeutics, Inc.

Material Agreement

Jan 5, 2026

8-KCompany UpdateDec 10, 2025

8-KReg FD Disclosure · Company UpdateDec 8, 2025

8-KResults of OperationsNov 6, 2025

8-KResults of OperationsAug 6, 2025

8-KShareholder VoteJun 25, 2025

8-KResults of OperationsMay 8, 2025

8-KResults of OperationsFeb 27, 2025

8-KReg FD DisclosureDec 17, 2024

8-KResults of OperationsNov 13, 2024

8-KExecutive Change · Reg FD DisclosureSep 17, 2024

8-KExecutive ChangeAug 27, 2024

8-KResults of OperationsAug 8, 2024

8-KShareholder Vote · Company UpdateJun 27, 2024

8-KCompany UpdateJun 3, 2024

8-KReg FD Disclosure · Company UpdateJun 3, 2024

8-KResults of OperationsMay 9, 2024

8-KResults of OperationsMar 8, 2024

8-KReg FD Disclosure · Company UpdateDec 18, 2023

8-KMaterial Agreement · Results of OperationsNov 14, 2023

8-KMaterial Agreement · Equity IssuanceSep 29, 2023

8-KReg FD DisclosureSep 29, 2023

8-KResults of OperationsAug 10, 2023

8-KExecutive ChangeAug 4, 2023

8-KMaterial AgreementJul 6, 2023

8-KAuditor ChangeJun 5, 2023

8-KResults of OperationsMay 11, 2023

8-KResults of OperationsMar 30, 2023

8-KBylaw AmendmentFeb 7, 2023

$71.7M

+13.1%

RYTMRHYTHM PHARMACEUTICALS, INC.$6.1B+0.2%